15 21

Cited 0 times in

A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era

DC FieldValueLanguage
dc.contributor.author신재일-
dc.contributor.author이금화-
dc.date.accessioned2020-09-29T00:42:10Z-
dc.date.available2020-09-29T00:42:10Z-
dc.date.issued2020-06-
dc.identifier.issn1010-660X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/179370-
dc.description.abstractBackground and objective: Despite medical advances, we are facing the unprecedented disaster of the coronavirus disease 2019 (COVID-19) pandemic without available treatments and effective vaccines. As the COVID-19 pandemic has approached its culmination, desperate efforts have been made to seek proper treatments and response strategies, and the number of clinical trials has been rapidly increasing. In this time of the pandemic, it is believed that learning lessons from it would be meaningful in preparing for future pandemics. Thus, this study aims at providing a comprehensive landscape of COVID-19 related clinical trials based on the ClinicalTrials.gov database. Materials and methods: Up to 30 March 2020, we identified a total of 147 eligible clinical trials and reviewed the overview of the studies. Results: Until then, the most clinical trials were set up in China. Treatment approaches are the most frequent purpose of the registered studies. Chloroquine, interferon, and antiviral agents such as remdesivir, lopinavir, and ritonavir are agents under investigation in these trials. Conclusions: In this study, we introduced the promising therapeutic options that many researchers and clinicians are interested in, and to address the hidden issues behind clinical trials in this COVID-19 pandemic.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherMDPI-
dc.relation.isPartOfMEDICINA-LITHUANIA-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHClinical Trials as Topic / statistics & numerical data*-
dc.subject.MESHCoronavirus Infections / therapy*-
dc.subject.MESHDatabases, Factual-
dc.subject.MESHHumans-
dc.subject.MESHPandemics-
dc.subject.MESHPneumonia, Viral / therapy*-
dc.titleA Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pediatrics (소아청소년과학교실)-
dc.contributor.googleauthorJinhee Lee-
dc.contributor.googleauthorHan Wul Shin-
dc.contributor.googleauthorJun Young Lee-
dc.contributor.googleauthorJae Seok Kim-
dc.contributor.googleauthorJae Won Yang-
dc.contributor.googleauthorKeum Hwa Lee-
dc.contributor.googleauthorAndreas Kronbichler-
dc.contributor.googleauthorJae Il Shin-
dc.identifier.doi10.3390/medicina56060315-
dc.contributor.localIdA02142-
dc.contributor.localIdA04622-
dc.contributor.localIdA04622-
dc.relation.journalcodeJ03886-
dc.identifier.eissn1648-9144-
dc.identifier.pmid32604775-
dc.subject.keywordCOVID-19-
dc.subject.keywordclinical trials-
dc.contributor.alternativeNameShin, Jae Il-
dc.contributor.affiliatedAuthor신재일-
dc.contributor.affiliatedAuthor이금화-
dc.contributor.affiliatedAuthor이금화-
dc.citation.volume56-
dc.citation.number6-
dc.citation.startPage315-
dc.identifier.bibliographicCitationMEDICINA-LITHUANIA, Vol.56(6) : 315, 2020-06-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.